12 insiders have filed at ASND since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Mikkelsen Jan Moller | Director | 453.4k | 0.746% | none | none |
| Sprogoe Kennett | See Remarks | 19.6k | 0.032% | none | none |
| Pedersen Anni Lotte Kirstine Sonderbjerg | EVP & Chief Admin Officer | 19.5k | 0.032% | none | none |
| Jensen Flemming Steen | See Remarks | 19.5k | 0.032% | none | none |
| Holtug Lars | Director | 4.2k | <0.01% | none | none |
| Cha Albert | Director | 3.7k | <0.01% | none | none |
| Smith Scott Thomas | EVP & Chief Financial Officer | 2.5k | <0.01% | none | none |
| Imani Siham | Director | 2.3k | <0.01% | none | none |
| Fairey William | Director | 2.1k | <0.01% | none | none |
| Morrison Lisa | Director | 1.6k | <0.01% | none | none |
| Wu Jay Donovan | EVP & President Us Market | 1.1k | <0.01% | none | none |
| Shu Aimee | EVP & Chief Medical Officer | none | none |
No open-market buys or sells have been reported at ASND since 2023Q3. The table shows the filed stakes; it updates when an insider files.
Full register at boothcheck.com/insiders/ASND. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.